Darden University of Virginia (USA)
-
Progressive Patents for Usage-Based Insurance
Doyle, Jacqueline L.; Ziegler, John S.Case DARDEN-OM-1578-EService and Operations ManagementThe material in this case presents Progressive Insurance as it faced important decisions regarding how to proceed with its usage-based insurance (UBI) initiatives, including the Snapshot device and related patents. Progressive had a head start on its competitors employing UBI pricing, but several competing insurance companies had been testing the waters with their own UBI products. In the case, Progressive considers a number of alternative uses ...Starting at €8.20
-
JWSM Construction: Building More Than a Rail Line
Doyle, Jacqueline L.; Linde, EricCase DARDEN-OM-1752-EService and Operations ManagementMarvin has just been tapped to assume control of a team of over 50 individuals tasked with completing a $40 million construction project over the next two years. His work package is part of a larger project to expand the footprint of a major city’s metropolitan railway network via construction of 10 miles of high-voltage rail and six large train stations. Although Marvin has worked at JWSM Construction, a general contractor, for three years, he’s...Starting at €8.20
-
Taking Action at the Kilbourne Group: Research Assistant Complications (B)
Doyle, Jacqueline L.; Alvarez Diaz, NataliaCase DARDEN-G-0663StrategyThis case, the epilogue to "Taking Action at the Kilbourne Group: Research Assistant Complications (A)" (UVA-G-0662Starting at €5.74
-
Teva Pharmaceuticals: Pricing the 2016 Bond Offering
Schill, Michael J.; Yates, AdamCase DARDEN-F-2028-EFinanceThis case examines the July 2016 decision by Israeli pharmaceutical Teva Pharmaceuticals Industries Limited (Teva) to raise USD19.5 billion in cash through a multicurrency bond offering to finance an acquisition that would firmly solidify Teva’s position as the largest generic pharmaceuticals manufacturer in the world. In light of a pending acquisition of Actavis, the generic drug manufacturing arm of Irish-US pharmaceutical Allergen Inc. (Allerg...Starting at €8.20
-
Teva Pharmaceuticals: Pricing the 2016 Bond Offering -Teaching note
Schill, Michael J.; Yates, AdamTeaching Note DARDEN-F-2028TN-EFinanceTeaching note for the product F-2028Starting at €0.00
-
Progressive Patents for Usage-Based Insurance -Teaching Note
Doyle, Jacqueline L.; Ziegler, John S.Teaching Note DARDEN-OM-1578TN-EService and Operations ManagementTeaching Note for productStarting at €0.00
-
Taking Action at the Kilbourne Group: Research Assistant Complications (A)
Doyle, Jacqueline L.; Alvarez Diaz, NataliaCase DARDEN-G-0662StrategyThis brief case, written in the second person, places student in the role of a fairly new research manager (RM) at the Kilbourne Group, a research and consulting firm serving public and private schools, ranging from K–12 to universities around the globe. The RM, who has been in the role for a little under a year, is faced with addressing the work patterns of a new subordinate, a research associate (RA) on the team. The RA, who is exceptionally ta...Starting at €8.20